Experts discuss why CIS is frequently underrecognized, highlighting the subtle clinical and cystoscopic features of the disease and the importance of integrating multiple factors to improve detection.
Multidisciplinary perspectives on high-risk NMIBC
Experts discuss practical strategies to improve the detection of CIS through closer urologist-pathologist collaboration, optimized biopsy techniques, and complementary diagnostic tools.
Advertisement
Advertisement
Trending on Urology Times
1
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
2
FDA grants tentative approval to generic olaparib tablets across previously approved indications
3
Experts discuss the challenge of detecting CIS in bladder cancer
4
Study shows durable 3-year outcomes with first-line gemcitabine/docetaxel in NMIBC
5